Aoxing Pharmaceutical Net Loss of -$1.92M

Aoxing Pharmaceutical (AXN): FQ2 Net Loss of -$1.92M.

Revenue of $3.46M (+5% Y/Y).

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs